Replies to post #1193 on Nephros Inc (NEPH)

[tape660]

Information is out there on their products. Take a look at this independent test done on the DSU filters.
The addition of the Nephros DSU to the dialysis water treatment system was able to reduce EPO usage significantly in this prospective observational trial.
At the beginning of the study, Clinic A and B were spending $17k and $24k per month on EPO for their 20 patients respectively. At the end of the study, these monthly costs had decreased to $9.5k and $14k respectively. Pre-MIPPA the clinic would suffer financially for this improvement at the ASP+6% reimbursement. However, in the bundled rate system, Clinic A would see a $28 savings ($64 vs. $36) in average EPO cost per treatment. Clinic B would see a $40 savings ($94 vs. $54) on EPO compared to the baseline. These differences would have a significant positive financial impact on the ability of dialysis clinics to manage ESA costs thereby allowing clinics to thrive.

http://www.biologicalwaterfilters.com/EPOReductiononMachinesPrevEquipwithUltrafilters.pdf

http://www.biologicalwaterfilters.com/hospital-water-filters/epo-reduction-after-installing-dsu-on-machines-equipped-with-machine-brand-ultrafilters/